See also this year's filing and all EDGAR filings for this company.
PDF Report 0001723128_2023_Amneal_Pharmaceuticals_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.016976822557888734, 'aggregate_val': 3799341000, 'exp_sum': 3735917000, 'exp_to_value': {'AssetsCurrent': 1411818000, 'IntangibleAssetsNetIncludingGoodwill': 1694946000, 'PropertyPlantAndEquipmentNet': 469815000, 'remainder_Assets': 159338000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001723128, Amneal Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,411,818,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,694,946,000 |
| 2 | PropertyPlantAndEquipmentNet | 469,815,000 |
| 3 | remainder_Assets | 222,762,000 |
| 4 | LiabilitiesCurrent | 752,800,000 |
| 5 | LiabilitiesNoncurrent | 2,837,613,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,416,485,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 399,700,000 |
| 9 | ResearchAndDevelopmentExpense | 195,688,000 |
| 10 | remainder_Expenses | 35,320,000 |
| 11 | remainder_Revenues | 2,212,304,000 |
| 12 | remainder_NetIncome | -419,900,000 |
| 13 | remainder_ComprehensiveNetIncome | 159,679,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,799,341,000 |
| 1 | Liabilities | 3,590,413,000 |
| 2 | Expenses | 2,047,193,000 |
| 3 | Revenues | 2,212,304,000 |
| 4 | StockholdersEquity | 208,928,000 |
| 5 | NetIncome | -254,789,000 |
| 6 | ComprehensiveNetIncome | -174,949,500 |
| 7 | BaseVar | 6,114,415,000 |
| 8 | EconomicCapitalRatio | 0.0499 |
Edgar->Model Mapping
Feature Distribution
Change over Time
